Small molecular agents based on glutamate urea showed folate hydrolase I activity and competitively inhibited the activity of NAALADase of PSMA, laying the foundation for high-affinity binding to PSMA expressed on prostate cancer cells [32,33]. This evidence concerns the gene FOLH1 and prostate cancer.